A rendering of the manufacturing installation of Eli Lilly in Houston, Texas.
With kind permission: Eli Lilly
Eli Lilly On Tuesday, he said that he would spend 6.5 billion dollars to build a manufacturing plant in Houston, Texas, to stimulate the production of the pipeline of the so -called molecules drugs, including its closely looked at its experimental obesity pill.
This is the second of a series of American investments provided by the drug manufacturer. Eli Lilly announced in February that he would spend at least $ 27 billion to build four new national manufacturing factories, which has increased 23 billion dollars in previous investments since 2020.
Eli Lilly said he will announce the two remaining American sites this year. The company plans to start doing medication in the four facilities within five years.
This additional production capacity for the Eli Lilly obesity pill, Orforglipron, is crucial while the company rushes to put it on the market and tries to maintain its domination in the booming market of GLP-1. Eli Lilly and Novo Nordisk have already faced supply constraints with their existing weekly injections, while demand soar in the United States
“Our new Houston site will improve Lilly’s ability to manufacture Orforglipron on a large scale and, if it is approved, will help to carry out the potential of the drug as obesity and a type 2 diabetes treatment for tens of millions of people in the world who prefer the ease of a pill that can be taken without food and water restrictions”, said Eli Lilly David Ricks in the version.
The manufacturers of drugs rushed to stimulate their production in the United States while President Donald Trump threatens to impose prices on imported pharmaceuticals in the United States, Trump has declared that these samples encourage companies to reflect production after the manufacture of domestic drugs is radically shrinking over the past decade.
In a statement on Tuesday, Eli Lilly said that the new Houston factory will focus on the manufacturing or for the company’s pipeline of other small molecules in different areas of disease, including cardiometabolic health, oncology, immunology and neuroscience. Small molecules drugs, which are often in the form of a pill, are more practical to take for patients than injectable drugs and are generally easier and cheaper to make on a large scale.
Eli Lilly said the site will bring 615 jobs in the Grand Houston region, including highly qualified engineers, scientists, operations staff and laboratory technicians, and 4,000 construction jobs.
